Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb This Week: Illumina, BioMérieux, and Agilent Technologies

Illumina TruSight Tumor 170

Illumina has launched TruSight Tumor 170, a next-generation sequencing-based panel that targets SNVs, gene amplifications, gene fusions, and splice variants found in 170 cancer-related genes. The panel analyzes both DNA and RNA and requires 40 nanograms of input from formalin-fixed paraffin-embedded samples. The panel will begin shipping in the first quarter 2017 for research use only.

BioMérieux EMAG

BioMérieux has launched eMAG, a molecular biology platform for the extraction of nucleic acids. The platform uses the company's BOOM technology, featuring automation from the primary sample tube, greater traceability, and higher throughput. The system can extract 48 samples in 90 minutes directly from a primary sample, and may be used with a broad variety of biological samples, including whole blood, plasma, serum, stool, respiratory samples, and cerebrospinal fluid.

Cartagenia Bench Lab 5.0

Agilent Technologies has released the Cartagenia Bench Lab 5.0. This version of the software includes new capabilities for somatic variant classification, review, curation, and reporting, the company said. The updated variant curation tools enable labs to build internal knowledgebases that contain predictive, prognostic, diagnostic, and functional evidence for variants. It accesses tumor type ontology and variant information from curated and public databases to help labs efficiently implement their variant assessment standard operating procedure and more effectively filter variants. The software provides direct access to more than 100 curated databases including CIViC, COSMIC, N-of-One, OncoMD, and CollabRx.

For more new products and services, please visit the New Products page on our website.